{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:36:20Z","timestamp":1788467780863,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s13318-023-00839-3","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T16:33:43Z","timestamp":1687192423000},"page":"427-435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Comparative Pharmacokinetics of Commercially Available Cannabidiol Isolate, Broad-Spectrum, and Full-Spectrum Products"],"prefix":"10.1007","volume":"48","author":[{"given":"Erin C.","family":"Berthold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam H.","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva Rama Raju","family":"Kanumuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria S.","family":"Senetra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hua","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance R.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0553-4039","authenticated-orcid":false,"given":"Abhisheak","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"839_CR1","unstructured":"Brenan M. 14% of Americans Say They Use CBD Products. 2019. https:\/\/news.gallup.com\/poll\/263147\/americans-say-cbd-products.aspx. Accessed 07 Mar 2023."},{"key":"839_CR2","unstructured":"Dorbian I. CBD Market Could Reach $20 Billion by 2024, Says New Study 2019. https:\/\/www.forbes.com\/sites\/irisdorbian\/2019\/05\/20\/cbd-market-could-reach-20-billion-by-2024-says-new-study\/?sh=7832ab1049d0. Accessed 07 Mar 2023."},{"issue":"1","key":"839_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1089\/can.2018.0006","volume":"3","author":"J Corroon","year":"2018","unstructured":"Corroon J, Phillips JA. A cross-sectional study of cannabidiol users. Cannabis Cannabinoid Res. 2018;3(1):152\u201361. https:\/\/doi.org\/10.1089\/can.2018.0006.","journal-title":"Cannabis Cannabinoid Res"},{"key":"839_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/SAR.S164261","volume":"10","author":"C Veltri","year":"2019","unstructured":"Veltri C, Grundmann O. Current perspectives on the impact of Kratom use. Subst Abuse Rehabil. 2019;10:23\u201331. https:\/\/doi.org\/10.2147\/SAR.S164261.","journal-title":"Subst Abuse Rehabil"},{"key":"839_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.yebeh.2018.07.027","volume":"88","author":"KA Schoedel","year":"2018","unstructured":"Schoedel KA, Szeto I, Setnik B, Sellers EM, Levy-Cooperman N, Mills C, et\u00a0al. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: a randomized, double-blind, controlled trial. Epilepsy Behav. 2018;88:162\u201371. https:\/\/doi.org\/10.1016\/j.yebeh.2018.07.027.","journal-title":"Epilepsy Behav"},{"issue":"21","key":"839_CR6","doi-asserted-by":"publisher","first-page":"12137","DOI":"10.1021\/acs.jmedchem.0c00724","volume":"63","author":"KM Nelson","year":"2020","unstructured":"Nelson KM, Bisson J, Singh G, Graham JG, Chen S-N, Friesen JB, et\u00a0al. The essential medicinal chemistry of cannabidiol (CBD). J Med Chem. 2020;63(21):12137\u201355. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00724.","journal-title":"J Med Chem"},{"key":"839_CR7","unstructured":"U.S. Food and Drug Administration. FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy. Silver Spring, MD; 2018. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms. Accessed 07 Mar 2023."},{"issue":"2\u20133","key":"839_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.phymed.2008.12.018","volume":"16","author":"H Wagner","year":"2009","unstructured":"Wagner H, Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine. 2009;16(2\u20133):97\u2013110. https:\/\/doi.org\/10.1016\/j.phymed.2008.12.018.","journal-title":"Phytomedicine"},{"issue":"1","key":"839_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0014-2999(98)00392-6","volume":"353","author":"S Ben-Shabat","year":"1998","unstructured":"Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, et\u00a0al. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharmacol. 1998;353(1):23\u201331. https:\/\/doi.org\/10.1016\/s0014-2999(98)00392-6.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"839_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1039\/a703973e","volume":"16","author":"R Mechoulam","year":"1999","unstructured":"Mechoulam R, Ben-Shabat S. From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis. Nat Prod Rep. 1999;16(2):131\u201343. https:\/\/doi.org\/10.1039\/a703973e.","journal-title":"Nat Prod Rep"},{"key":"839_CR11","unstructured":"115th Congress of the United States. Agriculture Improvement Act of 2018. 2018. Available from: https:\/\/uscode.house.gov\/statutes\/pl\/115\/334.pdf. Accessed 07 March 2023."},{"key":"839_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/978-3-030-31269-5_15","volume":"1","author":"D Cox-Georgian","year":"2019","unstructured":"Cox-Georgian D, Ramadoss N, Dona C, Basu C. Therapeutic and medicinal uses of terpenes. Med Plants. 2019;1:333\u201359. https:\/\/doi.org\/10.1007\/978-3-030-31269-5_15.","journal-title":"Med Plants"},{"issue":"1","key":"839_CR13","doi-asserted-by":"publisher","first-page":"8232","DOI":"10.1038\/s41598-021-87740-8","volume":"11","author":"JE LaVigne","year":"2021","unstructured":"LaVigne JE, Hecksel R, Keresztes A, Streicher JM. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Sci Rep. 2021;11(1):8232. https:\/\/doi.org\/10.1038\/s41598-021-87740-8.","journal-title":"Sci Rep"},{"issue":"4","key":"839_CR14","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1124\/pharmrev.120.000046","volume":"73","author":"E Liktor-Busa","year":"2021","unstructured":"Liktor-Busa E, Keresztes A, LaVigne J, Streicher JM, Largent-Milnes TM. Analgesic potential of terpenes derived from Cannabis sativa. Pharmacol Rev. 2021;73(4):1269\u201397. https:\/\/doi.org\/10.1124\/pharmrev.120.000046.","journal-title":"Pharmacol Rev"},{"issue":"8","key":"839_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/17512433.2020.1721281","volume":"13","author":"PS Cogan","year":"2020","unstructured":"Cogan PS. The \u201centourage effect\u201d or \u201chodge-podge hashish\u201d: the questionable rebranding, marketing, and expectations of cannabis polypharmacy. Expert Rev Clin Pharmacol. 2020;13(8):835\u201345. https:\/\/doi.org\/10.1080\/17512433.2020.1721281.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"2","key":"839_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/1570159X17666190903103923","volume":"18","author":"SG Ferber","year":"2020","unstructured":"Ferber SG, Namdar D, Hen-Shoval D, Eger G, Koltai H, Shoval G, et\u00a0al. The \u201cEntourage Effect\u201d: terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders. Curr Neuropharmacol. 2020;18(2):87\u201396. https:\/\/doi.org\/10.2174\/1570159X17666190903103923.","journal-title":"Curr Neuropharmacol"},{"key":"839_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4236\/pp.2015.62010","volume":"6","author":"R Gallily","year":"2015","unstructured":"Gallily R, Yekhtin Z, Hanua L. Overcoming the bell-shaped dose-response of cannabidiol by using cannabis extract enriched in cannabidiol. J Pharm Pharmacol. 2015;6:75\u201385.\u00a0https:\/\/doi.org\/10.4236\/pp.2015.62010","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"839_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","volume":"39","author":"JR Johnson","year":"2010","unstructured":"Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010;39(2):167\u201379. https:\/\/doi.org\/10.1016\/j.jpainsymman.2009.06.008.","journal-title":"J Pain Symptom Manage"},{"key":"839_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3389\/fneur.2018.00759","volume":"9","author":"FA Pamplona","year":"2018","unstructured":"Pamplona FA, da Silva LR, Coan AC. Potential clinical benefits of CBD-rich cannabis extracts over purified CBD in treatment-resistant epilepsy: observational data meta-analysis. Front Neurol. 2018;9:759. https:\/\/doi.org\/10.3389\/fneur.2018.00759.","journal-title":"Front Neurol"},{"key":"839_CR20","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3389\/fpls.2018.01969","volume":"9","author":"EB Russo","year":"2018","unstructured":"Russo EB. The case for the entourage effect and conventional breeding of clinical cannabis: no \u201cStrain\u201d, No Gain. Front Plant Sci. 2018;9:1969. https:\/\/doi.org\/10.3389\/fpls.2018.01969.","journal-title":"Front Plant Sci"},{"issue":"12","key":"839_CR21","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1211\/0022357022304","volume":"55","author":"JD Wilkinson","year":"2003","unstructured":"Wilkinson JD, Whalley BJ, Baker D, Pryce G, Constanti A, Gibbons S, et\u00a0al. Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects? J Pharm Pharmacol. 2003;55(12):1687\u201394. https:\/\/doi.org\/10.1211\/0022357022304.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"839_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/npp.2017.209","volume":"43","author":"DL Boggs","year":"2018","unstructured":"Boggs DL, Nguyen JD, Morgenson D, Taffe MA, Ranganathan M. Clinical and preclinical evidence for functional interactions of cannabidiol and \u03b49-tetrahydrocannabinol. Neuropsychopharmacology. 2018;43(1):142\u201354. https:\/\/doi.org\/10.1038\/npp.2017.209.","journal-title":"Neuropsychopharmacology"},{"key":"839_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fphar.2020.00359","volume":"11","author":"DB Finlay","year":"2020","unstructured":"Finlay DB, Sircombe KJ, Nimick M, Jones C, Glass M. Terpenoids from cannabis do not mediate an entourage effect by acting at cannabinoid receptors. Front Pharmacol. 2020;11:359. https:\/\/doi.org\/10.3389\/fphar.2020.00359.","journal-title":"Front Pharmacol"},{"issue":"3","key":"839_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/can.2018.0054","volume":"4","author":"HM Harris","year":"2019","unstructured":"Harris HM, Rousseau MA, Wanas AS, Radwan MM, Caldwell S, Sufka KJ, et\u00a0al. Role of cannabinoids and terpenes in cannabis-mediated analgesia in rats. Cannabis Cannabinoid Res. 2019;4(3):177\u201382. https:\/\/doi.org\/10.1089\/can.2018.0054.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"839_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1124\/jpet.104.080739","volume":"314","author":"SA Varvel","year":"2005","unstructured":"Varvel SA, Bridgen DT, Tao Q, Thomas BF, Martin BR, Lichtman AH. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. J Pharmacol Exp Ther. 2005;314(1):329\u201337. https:\/\/doi.org\/10.1124\/jpet.104.080739.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"839_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s42238-020-00050-0","volume":"2","author":"EC Berthold","year":"2020","unstructured":"Berthold EC, Yang R, Sharma A, Kamble SH, Kanumuri SR, King TI, et\u00a0al. Regulatory sampling of industrial hemp plant samples (Cannabis sativa L.) using UPLC-MS\/MS method for detection and quantification of twelve cannabinoids. J Cannabis Res. 2020;2(1):42. https:\/\/doi.org\/10.1186\/s42238-020-00050-0.","journal-title":"J Cannabis Res"},{"issue":"1","key":"839_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0378-5173(01)00698-6","volume":"222","author":"G Krishna","year":"2001","unstructured":"Krishna G, Chen K, Lin C, Nomeir AA. Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2. Int J Pharm. 2001;222(1):77\u201389. https:\/\/doi.org\/10.1016\/s0378-5173(01)00698-6.","journal-title":"Int J Pharm"},{"issue":"2","key":"839_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11626-997-0032-3","volume":"33","author":"M Mehran","year":"1997","unstructured":"Mehran M, Levy E, Bendayan M, Seidman E. Lipid, apolipoprotein, and lipoprotein synthesis and secretion during cellular differentiation in caco-2 cells. In Vitro Cell Dev Biol Anim. 1997;33(2):118\u201328. https:\/\/doi.org\/10.1007\/s11626-997-0032-3.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"839_CR29","unstructured":"U.S. Food and Drug Administration, Bioanalytical Method Validation Guidance for Industry. Silver Spring, MD; 2018. https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf. Accessed 07 Mar 2023."},{"key":"839_CR30","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3389\/fphar.2021.641210","volume":"12","author":"V Cocetta","year":"2021","unstructured":"Cocetta V, Governa P, Borgonetti V, Tinazzi M, Peron G, Catanzaro D, et\u00a0al. Cannabidiol isolated from Cannabis sativa L. protects intestinal barrier from in vitro inflammation and oxidative stress. Front Pharmacol. 2021;12:911. https:\/\/doi.org\/10.3389\/fphar.2021.641210.","journal-title":"Front Pharmacol"},{"issue":"1","key":"839_CR31","doi-asserted-by":"publisher","first-page":"14542","DOI":"10.1038\/s41598-017-15026-z","volume":"7","author":"A Zgair","year":"2017","unstructured":"Zgair A, Lee JB, Wong JCM, Taha DA, Aram J, Di Virgilio D, et\u00a0al. Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation. Sci Rep. 2017;7(1):14542. https:\/\/doi.org\/10.1038\/s41598-017-15026-z.","journal-title":"Sci Rep"},{"key":"839_CR32","doi-asserted-by":"publisher","first-page":"53086-e","DOI":"10.3791\/53086","volume":"102","author":"AM Nauli","year":"2015","unstructured":"Nauli AM, Whittimore JD. Using Caco-2 cells to study lipid transport by the intestine. J Visual Exp. 2015;102:53086-e. https:\/\/doi.org\/10.3791\/53086.","journal-title":"J Visual Exp"},{"issue":"28","key":"839_CR33","doi-asserted-by":"publisher","first-page":"19565","DOI":"10.1074\/jbc.274.28.19565","volume":"274","author":"J Luchoomun","year":"1999","unstructured":"Luchoomun J, Hussain MM. Assembly and secretion of chylomicrons by differentiated Caco-2 cells: nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly. J Biol Chem. 1999;274(28):19565\u201372. https:\/\/doi.org\/10.1074\/jbc.274.28.19565.","journal-title":"J Biol Chem"},{"key":"839_CR34","unstructured":"Megias MMP, Pombal MA: Atlas of Plant and Animal Histology; 2019. http:\/\/mmegias.webs.uvigo.es\/index.html. Accessed 07 Mar 2023."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-023-00839-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-023-00839-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-023-00839-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T22:14:12Z","timestamp":1688595252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-023-00839-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1007\/s13318-023-00839-3","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"6 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ECB: conceptualization, methodology, investigation, data curation, writing\u2014original draft, preparation. SHK, SRRK, and MAK: methodology, investigation, writing\u2014review and editing. ASS and YHC: investigation, writing\u2014review and editing. LRM and CRM: supervision, material supply, review and editing, AS: conceptualization, funding acquisition, methodology, investigation, supervision, review and editing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors contributions"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the animal studies were performed after approval from the University of Florida Institutional Animal Care and Use Committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The data that support the findings of this study are available upon reasonable request to the corresponding author.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This project is part of the University of Florida\u2019s \u201cCreating the Healthiest Generation\u201d\u00a0Moonshot\u00a0Initiative, which is supported by the UF Office of the Provost, UF Office of Research, UF Health, UF College of Medicine, and the UF Clinical and Translational Science Institute.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}